Gyermekkori daganatok: vizsgálatok itt: Kína
609 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Beijing, Chengdu, Guangzhou, Shanghai
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - 1/2. fázisTaking peopleStudy of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Where
- Guangzhou, Tianjin
- Életkor
- 12 év and over
- People
- 83 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00 - No phaseTaking peopleShanghai Clinical Cohort - Esophageal Cancer
- Where
- Shanghai
- People
- 3500
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT07312526 - 2. fázisTaking peopleInaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1
- Where
- Shanghai
- Életkor
- 16 év to 70 év
- People
- 20
- Run by
- Ruijin Hospital
See details and how to joinNCT06718244 - No phaseTaking peopleNational Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
- Where
- Tianjin
- People
- 9999
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07019766 - 1/2. fázisTaking peopleDual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma
- Where
- Shenzhen
- Életkor
- 12 hónap to 21 év
- People
- 36
- Run by
- Beijing Biotech
See details and how to joinNCT07502287 - No phaseTaking peopleChinese Multicenter Registry for Peutz-Jeghers Syndrome
- Where
- Beijing, Fuzhou, Guangzhou, Hangzhou, Jinan, Shanghai, Tianjin
- People
- 1000
- Run by
- First People's Hospital of Hangzhou
See details and how to joinNCT07889596 - 4. fázisTaking peopleDabrafenib and/or Trametinib Rollover Study
- Where
- Beijing
- Életkor
- 18 év to 100 év
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - 3. fázisTaking peopleStudy of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
- Where
- Beijing, Changde, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Hangzhou, Harbin, Kunming, Lanzhou, Linyi, Luzhou, Nanchang, Shandong, Shanghai, Shenyang, Shenzhen, Tianjin, Wuhan, Xi'an, Yibin, Yinchuan, Zhengzhou, Zhuzhou
- Életkor
- 15 év and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06079671 · EU 2023-504374-38-00 - 2. fázisTaking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Tianjin, Zhengzhou
- Életkor
- 1 év to 18 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - 1. fázisTaking peopleCD19 Sequential CD22 In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
- Where
- Beijing
- Életkor
- 14 év to 75 év
- People
- 12
- Run by
- Liping Dou
See details and how to joinNCT07927816 - 1. fázisTaking peopleA Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- Where
- Beijing, Chengdu, Guangdong, Hangzhou, Nanjing, Shanghai, Shenyang, Shijiazhuang, Xian, Zhengzhou
- Életkor
- 12 év and over
- People
- 276 worldwide
- Run by
- Abbisko Therapeutics Co, Ltd
See details and how to joinNCT04192344 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Shanghai, Shenyang, Tianjin, Wuhan, Xian, Zhengzhou
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - No phaseTaking peopleWhole-slide Image and CT Radiomics Based Deep Learning System for Prognostication Prediction in Bladder Cancer
- Where
- Chongqing
- People
- 2000
- Run by
- Mingzhao Xiao
See details and how to joinNCT06389019 - No phaseCsak meghívásosLong-term Follow-up Study in Subjects With Multiple Myeloma Previously Treated With GC012F Injection
- Where
- Shanghai
- People
- 40
- Run by
- RenJi Hospital
See details and how to joinNCT07833046 - 3. fázisTaking peopleA Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
- Where
- Beijing, Changchun, Chengdu, Guangzhou, Hangzhou, Harbin, Hefei, Meizhou, Nanchang, Nanjing, Shanghai, Tianjin, Wuhan, Xiamen, Xi'an, XI 'an City, Shaanxi Province, Xinxiang, Zhengzhou
- People
- 200 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05862285 · EU 2023-504263-16-00 - No phaseTaking peoplePre- and On-treatment Multi-omics Profiling of Locally Advanced Rectal Cancer
- Where
- Fuzhou
- People
- 100
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT07920770 - No phaseNot yet taking people in KínaAutomated Radiation Target Contouring and Treatment Planning Via RATA: A Multi-Center RCT
- Where
- Guangzhou
- People
- 62
- Run by
- zhaoxiaohui
See details and how to joinNCT07922902 - 1/2. fázisTaking peopleA Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Chengdu, Guangzhou, Nanning
- Életkor
- 6 hónap to 30 év
- People
- 65 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05533775 - No phaseTaking peopleStudy of Anxiety and Depression in Patients With Hematologic Malignancies
- Where
- Xiamen
- People
- 100
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07883070 - No phaseNot yet taking people in KínaBusulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCT
- Where
- Beijing
- Életkor
- 14 év to 65 év
- People
- 180
- Run by
- Peking University People's Hospital
See details and how to joinNCT07919470 - 1/2. fázisTaking peopleA Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
- Where
- Beijing, Changchun, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing, Tianjin, Wenzhou, Wuhan, Zhengzhou
- Életkor
- 2 év and over
- People
- 420 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT04811560 · EU 2023-506581-31-00 - No phaseNot yet taking people in KínaMulti-center Prospective Validation of Real-Time AI-EGGIM System
- Where
- Binzhou, Jinan, Qingdao
- People
- 540
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07915843 - No phaseTaking peopleRetroperitoneal Tumor Registry
- Where
- Changchun
- People
- 200
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT07915895 - 1/2. fázisNot yet taking people in KínaMulti-CAR T Cell Therapy for Acute Myeloid Leukemia
- Where
- Shenzhen
- Életkor
- 2 év to 75 év
- People
- 10
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT03222674